Vesalius Longevity Labs Inc. funding
Vesalius Longevity Labs Inc., a pharmaceuticals company based in Vancouver, British Columbia, Canada, filed a Form D with the SEC on November 3, 2026 and reported $30.1M raised.
Amount raised$30.1M
Offering size$30.1M
Filed with the SECNovember 3, 2026
First saleOctober 28, 2026
IndustryPharmaceuticals
SecuritiesEquity
LocationVancouver, British Columbia, Canada
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far62
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Nov 3
Other health care rounds
Zai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyKaigene, Inc.$55M · Oct 14BiotechnologyAI3 Bio, Inc.$48.3M · Nov 4BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyNanopath Inc$29.9M · Nov 13Biotechnology